[INM] YoY Annual Result on 30-Jun-2020 [#FY]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
30-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#FY]
Profit Trend
YoY- 10.69%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Annual Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 4,136 1,089 0 0 0 0 0 -
PBT -7,935 -18,600 -10,203 -8,681 -10,097 -6,708 -3,440 14.93%
Tax 13 4,808 360 19 -262 -70 0 -
NP -7,948 -18,600 -10,200 -8,940 -10,010 -6,708 -3,440 14.97%
Tax Rate - - - - - - - -
Total Cost 12,083 19,690 10,200 8,940 10,010 6,708 3,440 23.28%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -192.18 -1,707.32 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -3.25 -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -31.58%
EPS Diluted -3.25 -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -31.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.